Stock analysts at StockNews.com initiated coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Free Report) in a note issued to investors on Monday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Down 3.8 % Shares of NASDAQ VBLT opened at $0.23 on Monday. Vascular Biogenics has a 52-week […]
Vascular Biogenics (NASDAQ:VBLT – Get Free Report) and Eyenovia (NASDAQ:EYEN – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, earnings and valuation. Analyst Recommendations This is a summary of recent […]
StockNews.com started coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a report released on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance NASDAQ VBLT opened at $0.24 on Friday. Vascular Biogenics has a 12 month low of $0.10 and a 12 month high […]
StockNews.com initiated coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research note released on Friday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Up 5.2 % VBLT opened at $0.24 on Friday. The stock has a market cap of $18.94 million, a PE ratio […]
StockNews.com initiated coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research note released on Thursday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance Shares of NASDAQ VBLT opened at $0.22 on Thursday. The firm’s 50-day simple moving average is $0.26 and its 200 day […]